Table of Contents

Articles

• You have access

  METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450

  Xiaochao Ma, Jeffrey R. Idle, Kristopher W. Krausz and Frank J. Gonzalez

  Drug Metabolism and Disposition April 2005, 33 (4) 489-494; DOI: https://doi.org/10.1124/dmd.104.002410
• You have access

  TRANSPORT OF THE DOPAMINE D₂ AGONIST PRAMIPEXOLE BY RAT ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 IN KIDNEY

  Naoki Ishiguro, Asami Saito, Kazutoshi Yokoyama, Makoto Morikawa, Takashi Igarashi and Ikumi Tamai

  Drug Metabolism and Disposition April 2005, 33 (4) 495-499; DOI: https://doi.org/10.1124/dmd.104.002519
• You have access

  CYTOCHROME P450 3A-MEDIATED METABOLISM OF BUSPIRONE IN HUMAN LIVER MICROSOMES

  Mingshe Zhu, Weiping Zhao, Humberto Jimenez, Donglu Zhang, Suresh Yeola, Renke Dai, Nimish Vachharajani and James Mitroka

  Drug Metabolism and Disposition April 2005, 33 (4) 500-507; DOI: https://doi.org/10.1124/dmd.104.000836
• You have access

  IN VITRO METABOLISM OF DIARYLPYRAZOLES, A NOVEL GROUP OF CANNABINOID RECEPTOR LIGANDS

  Qiang Zhang, Peng Ma, Weiqun Wang, Richard B. Cole and Guangdi Wang

  Drug Metabolism and Disposition April 2005, 33 (4) 508-517; DOI: https://doi.org/10.1124/dmd.104.001974
• You have access

  CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B

  Hiroki Satoh, Fumiaki Yamashita, Masayuki Tsujimoto, Hideyasu Murakami, Noriko Koyabu, Hisakazu Ohtani and Yasufumi Sawada

  Drug Metabolism and Disposition April 2005, 33 (4) 518-523; DOI: https://doi.org/10.1124/dmd.104.002337
• You have access

  EXPRESSION AND FUNCTION OF ABCB1 AND ABCG2 IN HUMAN PLACENTAL TISSUE

  Dhanashri Kolwankar, Douglas D. Glover, Joseph A. Ware and Timothy S. Tracy

  Drug Metabolism and Disposition April 2005, 33 (4) 524-529; DOI: https://doi.org/10.1124/dmd.104.002261
• You have access

  STRUCTURAL AND ENZYMATIC PARAMETERS THAT DETERMINE ALKYL DEHYDROGENATION/HYDROXYLATION OF CAPSAICINOIDS BY CYTOCHROME P450 ENZYMES

  Christopher A. Reilly and Garold S. Yost

  Drug Metabolism and Disposition April 2005, 33 (4) 530-536; DOI: https://doi.org/10.1124/dmd.104.001214
• You have access

  DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1

  Cuiping Chen, Rouchelle J. Mireles, Scott D. Campbell, Jian Lin, Jessica B. Mills, Jinghai J. Xu and Teresa A. Smolarek

  Drug Metabolism and Disposition April 2005, 33 (4) 537-546; DOI: https://doi.org/10.1124/dmd.104.002477
• You have access

  FUNCTIONAL INDUCTION AND DE-INDUCTION OF P-GLYCOPROTEIN BY ST. JOHN'S WORT AND ITS INGREDIENTS IN A HUMAN COLON ADENOCARCINOMA CELL LINE

  Run Tian, Noriko Koyabu, Satoshi Morimoto, Yukihiro Shoyama, Hisakazu Ohtani and Yasufumi Sawada

  Drug Metabolism and Disposition April 2005, 33 (4) 547-554; DOI: https://doi.org/10.1124/dmd.104.002485
• You have access

  ISOLATION AND IDENTIFICATION OF SEVEN GLUCURONIDE CONJUGATES OF ANDROGRAPHOLIDE IN HUMAN URINE

  Liang Cui, Feng Qiu and Xinsheng Yao

  Drug Metabolism and Disposition April 2005, 33 (4) 555-562; DOI: https://doi.org/10.1124/dmd.104.001958
• You have access

  HUMAN LIVER S9 FRACTIONS: METABOLISM OF DEHYDROEPIANDROSTERONE, EPIANDROSTERONE, AND RELATED 7-HYDROXYLATED DERIVATIVES

  Sonia Chalbot and Robert Morfin

  Drug Metabolism and Disposition April 2005, 33 (4) 563-569; DOI: https://doi.org/10.1124/dmd.104.003004
• You have access

  CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OF N-HYDROXYMELAGATRAN AND BENZAMIDOXIME

  Susanne Andersson, Yvonne Hofmann, Åsa Nordling, Xue-qing Li, Sabina Nivelius, Tommy B. Andersson, Magnus Ingelman-Sundberg and Inger Johansson

  Drug Metabolism and Disposition April 2005, 33 (4) 570-578; DOI: https://doi.org/10.1124/dmd.104.002972
• You have access

  EFFECT OF EARLY PHASE ADJUVANT ARTHRITIS ON HEPATIC P450 ENZYMES AND PHARMACOKINETICS OF VERAPAMIL: AN ALTERNATIVE APPROACH TO THE USE OF AN ANIMAL MODEL OF INFLAMMATION FOR PHARMACOKINETIC STUDIES

  Spencer Ling and Fakhreddin Jamali

  Drug Metabolism and Disposition April 2005, 33 (4) 579-586; DOI: https://doi.org/10.1124/dmd.104.002360
• You have access

  SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV

  Don K. Walker, Samantha Abel, Pierre Comby, Gary J. Muirhead, Angus N. R. Nedderman and Dennis A. Smith

  Drug Metabolism and Disposition April 2005, 33 (4) 587-595; DOI: https://doi.org/10.1124/dmd.104.002626
• You have access

  BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME

  Norito Takamura, Toru Maruyama, Etsuo Chosa, Keiichi Kawai, Yasuhiro Tsutsumi, Yukie Uryu, Keishi Yamasaki, Tsuneo Deguchi and Masaki Otagiri

  Drug Metabolism and Disposition April 2005, 33 (4) 596-602; DOI: https://doi.org/10.1124/dmd.104.002782